CLINICAL_TRIALS
trial_result
· 2016-01-11
Clinical Trial Update: A Phase II Study of Pemetrexed and Carboplatin in the Treatment of Esophageal Cancer [Phase 2]
Summary
Phase II study evaluating pemetrexed with carboplatin for esophageal cancer was terminated, with results posted in 2016.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Washington University School of Medicine | Conditions: Esophageal Neoplasms | Phase 2 | Status: TERMINATED | Results posted: 2016-01-11